Skip to content

Clinical trials

Completed Myelodysplastic Syndromes trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Completed Country / region: Switzerland Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20041
20051
20071
20081
20091
20101
20111
20151
20161
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
European Organisation for Research and Treatment of Cancer - EORTC2
Amgen1
Celgene1
Celgene Corporation1
Children's Oncology Group1
Fred Hutchinson Cancer Center1
OncoVerity, Inc.1
Prelude Therapeutics1
Swiss Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes15
Leukemia, Myeloid, Acute6
Leukemia4
Leukemia, Myelomonocytic, Chronic4
Anemia, Refractory, with Excess of Blasts3
Anemia, Refractory2
Congenital Abnormalities2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myelomonocytic, Juvenile2
Lymphoma2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.